Bob Myers's most recent trade in Predictive Oncology Inc was a trade of 8,795 Common Stock done at an average price of $0.6 . Disclosure was reported to the exchange on Dec. 2, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Predictive Oncology Inc | Bob Myers | CHIEF FINANCIAL OFFICER | Purchase of securities on an exchange or from another person at price $ 0.57 per share. | 02 Dec 2022 | 8,795 | 71,265 (1%) | 0% | 0.6 | 5,001 | Common Stock |
| Predictive Oncology Inc | Bob Myers | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Sep 2022 | 33,333 | 72,669 (1%) | 0% | - | Common Stock | |
| Predictive Oncology Inc | Bob Myers | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Sep 2022 | 33,333 | 33,333 | - | - | Restricted Stock Units | |
| Predictive Oncology Inc | Bob Myers | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.39 per share. | 23 Sep 2022 | 10,199 | 62,470 (1%) | 0% | 0.4 | 4,028 | Common Stock |
| Predictive Oncology Inc | Bob Myers | CHIEF FINANCIAL OFFICER | Purchase of securities on an exchange or from another person at price $ 0.30 per share. | 20 May 2022 | 16,125 | 39,336 (0%) | 0% | 0.3 | 4,889 | Common Stock |
| Predictive Oncology Inc | Bob Myers | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.13 per share. | 23 Sep 2021 | 33,334 | 33,411 (0%) | 0% | 1.1 | 37,667 | Common Stock, $.01 par value |
| Predictive Oncology Inc | Bob Myers | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Sep 2021 | 33,334 | 66,666 | - | - | Restricted Stock Units | |
| Predictive Oncology Inc | Bob Myers | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 1.13 per share. | 23 Sep 2021 | 10,200 | 23,211 (0%) | 0% | 1.1 | 11,526 | Common Stock, $.01 par value |
| Predictive Oncology Inc | Bob Myers | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2020 | 100,000 | 100,000 | - | - | Restricted Stock Units | |
| Predictive Oncology Inc | Bob Myers | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Sep 2020 | 30,411 | 0 | - | - | Stock Options (Right to buy) | |
| Predictive Oncology Inc | Bob Myers | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Sep 2020 | 30,411 | 30,411 | - | - | Stock Options (Right to buy) | |
| Predictive Oncology Inc | Bob Myers | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Sep 2020 | 16,600 | 16,600 | - | - | Stock Options (right to buy) | |
| Predictive Oncology Inc | Bob Myers | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Sep 2020 | 16,600 | 0 | - | - | Stock Options (Right to buy) | |
| Predictive Oncology Inc | Bob Myers | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Sep 2020 | 357 | 0 | - | - | Stock Options (Right to buy) | |
| Predictive Oncology Inc | Bob Myers | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Sep 2020 | 357 | 357 | - | - | Stock Options (Right to buy) | |
| Predictive Oncology Inc | Bob Myers | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Sep 2020 | 53 | 0 | - | - | Stock Options | |
| Predictive Oncology Inc | Bob Myers | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Sep 2020 | 53 | 53 | - | - | Stock Options (Right to buy) | |
| Predictive Oncology Inc | Bob Myers | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Sep 2020 | 42 | 0 | - | - | Stock Options (Right to buy) | |
| Predictive Oncology Inc | Bob Myers | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Sep 2020 | 42 | 42 | - | - | Stock Options (Right to buy) | |
| Predictive Oncology Inc | Bob Myers | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Sep 2020 | 14 | 0 | - | - | Stock Options (Right to buy) | |
| Predictive Oncology Inc | Bob Myers | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Sep 2020 | 14 | 14 | - | - | Stock Options (Right to buy) |